Close

Trending

PARP rivals close in on AZ and Merck’s market leading Lynparza

Unlocking the potential of connected commercialisation solutions

Considerations for Mobile Health Technology Developers: Part 2

Novo Nordisk achieve headline results with icodec insulin

Roche gets FDA approval for HER2 breast cancer diagnostic

UK & Europe

UK & Europe

thumbnail_boy_with_injection

Market Access/ News/ News/ Rare diseases/ Top stories/ UK & Europe

Patients call for end to two-year row over CF drug funding

Richard Staines cystic fibrosis, market access, NICE, Rare diseases, Vertex 0 Comment

UK patients are stepping up efforts to resolve the “heartbreaking” row that is denying their families access to

X

Patients call for end to two-year row over CF drug funding

https://pharmaphorum.com/news/patients-call-for-end-to-two-year-row-over-cf-drug-funding/

NHS Building

News/ Top stories/ UK & Europe

Theresa May’s NHS funding pledge insufficient – campaigners

Joy Persaud mental health, NHS 0 Comment

Campaigners have said Prime Minister Theresa May’s pledge to boost NHS coffers by £20 billion a year will

X

Theresa May’s NHS funding pledge insufficient – campaigners

https://pharmaphorum.com/news/more-questions-than-answers-after-mays-nhs-cash-pledge/

Biobanking Event

Partner content/ Press releases/ UK & Europe

New Speakers and Sponsor announced for 8th Annual BioBanking Conference

Maria Mandic Biobanking, biorepositories, biosample management, conference, openspecimen 0 Comment

New speakers and sponsor announced for BioBanking 2018

X

New Speakers and Sponsor announced for 8th Annual BioBanking Conference

https://pharmaphorum.com/partner-content/new-speakers-and-sponsor-announced-for-8th-annual-biobanking-conference/

Neuron_in_tissue_culture

News/ UK & Europe

e-Therapeutics and C4XD research Parkinson’s drugs

Richard Staines C4XD, e-Therapeutics, neurology, Parkinson's disease 0 Comment

Biotechs search for new treatments for incurable disease

X

e-Therapeutics and C4XD research Parkinson’s drugs

https://pharmaphorum.com/news/e-therapeutics-and-c4xd-research-parkinsons-drugs/

Lungs-16-9

Market Access/ News/ News/ UK & Europe

Vertex says ‘some way’ to CF drug price deal after NHS meeting

Richard Staines cystic fibrosis, market access, Vertex 0 Comment

Representatives of Vertex Pharmaceuticals and NHS England met last week in an attempt to end a two-year long

X

Vertex says ‘some way’ to CF drug price deal after NHS meeting

https://pharmaphorum.com/news/vertex-says-some-way-to-cf-drug-price-deal-after-nhs-meeting/

Lungs-2-16-9

GlaxoSmithKline/ News/ UK & Europe

FDA approves expanded use for GSK’s COPD triple therapy

Richard Staines COPD, GlaxoSmithKline, respiratory 0 Comment

GSK is aiming to revive its respiratory drugs franchise

X

FDA approves expanded use for GSK’s COPD triple therapy

https://pharmaphorum.com/news/fda-approves-expanded-use-for-gsks-copd-triple-therapy/

Business Team Brainstorming Data Target Financial Cocnept

Digital/ News/ News/ Top stories/ UK & Europe

Pharma playing catch-up as GDPR deadline nears

Joy Persaud digital health, GDPR 0 Comment

Pharma will need to change its culture

X

Pharma playing catch-up as GDPR deadline nears

https://pharmaphorum.com/news/pharma-playing-catch-up-as-gdpr-deadline-nears/

Shire HQ

M&A/ News/ UK & Europe/ US

Shire recommends Takeda’s £46bn bid

Richard Staines M&A, Shire, Takeda 0 Comment

Takeda’s shares sharply as mega-merger edges closer

X

Shire recommends Takeda’s £46bn bid

https://pharmaphorum.com/news/shire-recommends-takedas-46bn-bid/

Shire HQ

M&A/ News/ Top stories/ UK & Europe

Takeda woos Shire shareholders with increased bid

Richard Staines M&A, Shire, Takeda 0 Comment

Fourth and probably final bid has increased cash component

X

Takeda woos Shire shareholders with increased bid

https://pharmaphorum.com/news/takeda-woos-shire-shareholders-with-increased-bid/

«‹ 3 4 5 6 ›»

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com